Can We Wait To Take The Economic Loss On Weight Loss
The Gist
Navigating the Economics of Weight Loss Drugs
The chapter delves into the financial implications of providing a weight loss drug at a high cost to a large population, examining the potential burdens on individuals and the US government. It discusses the societal perspective on funding such drugs, eligibility criteria, and strategies to make them more accessible. The conversation also explores the complexities of drug regulation, pricing models based on social value, and the balance between profit margins and public health impact.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
